• Leveljump Healthcare Corp. (JUMP) will not be proceeding with its purchase of Telehospital Corp.
  • The transaction was originally scheduled for the end of June, 2022
  • Leveljump Healthcare is a leader in business-to-business (B2B) telehealth solutions
  • LevelJump Healthcare Corp. (TSXV:JUMP) opened trading at C$0.075

Leveljump Healthcare Corp. (JUMP) will not be proceeding with its previously announced purchase of Telehospital Corp.

The transaction was initially scheduled to close at the end of June 2022, but the vendors demanded certain last-minute adjustments, which Leveljump did not accept.

Leveljump continues looking for acquisitions to complement and expand its existing operations.

Leveljump Healthcare is a leader in business-to-business (B2B) telehealth solutions.

LevelJump Healthcare Corp. (TSXV:JUMP) opened trading at C$0.075.

More From The Market Online

Calian scores $23 million Canadian Armed Forces contract

Calian Group Ltd. (TSX:CGY) has been awarded a $17 million contract by the Canadian Armed Forces’ Canadian Forces Health Services Group.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

This life sciences company is gearing up to treat long COVID  

Revive Therapeutics (CSE:RVV), a Toronto-based company, has immense potential to capitalize on treating long COVID symptoms.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.